Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Soft-tissue Sarcoma”

767 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 767 results

Early research (Phase 1)Study completedNCT02897375
What this trial is testing

Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors

Who this might be right for
Solid NeoplasmStage III Pancreatic CancerStage IIIA Breast Cancer+14 more
Emory University 71
Testing effectiveness (Phase 2)Study completedNCT00002974
What this trial is testing

Whole-Body Hyperthermia Plus Chemotherapy in Treating Patients With Advanced Sarcoma

Who this might be right for
Sarcoma
University of Wisconsin, Madison 34
Early research (Phase 1)Looking for participantsNCT05691504
What this trial is testing

Testing the Combination of APG-1252 (Pelcitoclax) and Cobimetinib in Recurrent Ovarian and Endometrial Cancers

Who this might be right for
Advanced Endometrial CarcinomaMetastatic Endometrial CarcinomaMetastatic Fallopian Tube Carcinoma+8 more
National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)UnknownNCT03880695
What this trial is testing

Anlotinib Hydrochloride Combined With Liposomal Doxorubicin in the Treatment of Locally Advanced or Metastatic Soft Tissue Sarcoma

Who this might be right for
Sarcoma
Peking University People's Hospital 48
Testing effectiveness (Phase 2)Study completedNCT02797977
What this trial is testing

A Phase 1/2 Trial SRA737 in Combination With Gemcitabine and Cisplatin or Gemcitabine Alone in Advanced Cancer Subjects

Who this might be right for
Advanced Solid Tumors
Sierra Oncology LLC - a GSK company 153
Testing effectiveness (Phase 2)UnknownNCT03816475
What this trial is testing

Hypofractionated Radiotherapy in Locally Advanced Myxoid Liposarcomas of Extremities or Trunk Wall (LIPO-MYX Trial)

Who this might be right for
Myxoid Liposarcoma
Maria Sklodowska-Curie National Research Institute of Oncology 35
Testing effectiveness (Phase 2)Study completedNCT01814501
What this trial is testing

Panitumumab and Chemotherapy in Patients With Advanced Colorectal Cancer After Prior Therapy With Bevacizumab

Who this might be right for
Mucinous Adenocarcinoma of the ColonMucinous Adenocarcinoma of the RectumRecurrent Colon Cancer+5 more
John Hays 16
Large-scale testing (Phase 3)Active Not RecruitingNCT03784014
What this trial is testing

Molecular Profiling of Advanced Soft-tissue Sarcomas

Who this might be right for
Soft Tissue Sarcoma
Institut National de la Santé Et de la Recherche Médicale, France 603
Early research (Phase 1)Looking for participantsNCT05711615
What this trial is testing

Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma

Who this might be right for
Metastatic Dedifferentiated LiposarcomaMetastatic LeiomyosarcomaMetastatic Myxofibrosarcoma+9 more
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Ended earlyNCT02441309
What this trial is testing

A Eurosarc Study of Mifamurtide in Advanced Osteosarcoma (MEMOS)

Who this might be right for
Osteosarcoma
University of Oxford 8
Early research (Phase 1)Study completedNCT00722293
What this trial is testing

A Phase I, Open-label, Study of Pazopanib in Combination With Epirubicin or Doxorubicin for Advanced Solid Tumors

Who this might be right for
Neoplasms, Breast
GlaxoSmithKline 111
Testing effectiveness (Phase 2)Study completedNCT03277924
What this trial is testing

Trial of Sunitinib and/or Nivolumab Plus Chemotherapy in Advanced Soft Tissue and Bone Sarcomas

Who this might be right for
Soft Tissue SarcomaBone Sarcoma
Grupo Espanol de Investigacion en Sarcomas 197
Very early researchLooking for participantsNCT06171282
What this trial is testing

A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Bone and Soft Tissue Tumors

Who this might be right for
OsteosarcomaSarcomaSoft Tissue Sarcoma+1 more
Shanghai Yunying Medical Technology 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT06630325
What this trial is testing

A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer

Who this might be right for
Advanced Breast CarcinomaAdvanced Malignant Solid NeoplasmAdvanced Ovarian Carcinoma+11 more
OHSU Knight Cancer Institute 30
Testing effectiveness (Phase 2)UnknownNCT02630368
What this trial is testing

Metronomic CP and JX-594 in Patients With Advanced Breast Cancer and Advanced Soft-tissue Sarcoma (METROmaJX)

Who this might be right for
Solid TumorsSoft-tissue SarcomaBreast Cancer
Institut Bergonié 197
Large-scale testing (Phase 3)Study completedNCT02711007
What this trial is testing

Apatinib for Advanced Osteosarcoma After Failure of Standard Multimodal Therapy

Who this might be right for
OsteosarcomaMetastasis
GUO WEI 37
Testing effectiveness (Phase 2)Looking for participantsNCT06528769
What this trial is testing

Study of All-Trans Retinoic Acid (ATRA) and Cemiplimab in Patients With Advanced Leiomyosarcoma

Who this might be right for
LeiomyosarcomaSarcoma
Gabriel Tinoco 16
Not applicableLooking for participantsNCT05835154
What this trial is testing

A Checklist (Advanced Care Planning) for The Assessment of Mobility Needs in Patients With Sarcoma

Who this might be right for
Metastatic SarcomaSarcoma
Fred Hutchinson Cancer Center 20
Not applicableUnknownNCT03621332
What this trial is testing

HRQoL in Advanced Soft Tissue Sarcoma Patients Treated With Chemotherapy.

Who this might be right for
Quality of Life
Royal Marsden NHS Foundation Trust 132
Testing effectiveness (Phase 2)Active Not RecruitingNCT03213652
What this trial is testing

Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmMalignant Solid NeoplasmRecurrent Ependymoma+30 more
National Cancer Institute (NCI) 13
Load More Results